Literature DB >> 4887691

A controlled trial of carbenoxolone sodium capsules in the treatment of duodenal ulcer.

R D Montgomery, I H Lawrence, D J Manton, K Mendl, P Rowe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4887691      PMCID: PMC1552871          DOI: 10.1136/gut.9.6.704

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  TREATMENT OF GASTRIC ULCER WITH CARBENOXOLONE SODIUM AND OESTROGENS.

Authors:  R DOLL; I D HILL; C F HUTTON
Journal:  Gut       Date:  1965-02       Impact factor: 23.059

Review 2.  Carbenoxolone sodium.

Authors:  M J Langman
Journal:  Gut       Date:  1968-02       Impact factor: 23.059

3.  Carbenoxolone in the treatment of duodenal ulcer.

Authors:  O Craig; T Hunt; J J Kimerling; D V Parke
Journal:  Practitioner       Date:  1967-07

4.  Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects.

Authors:  A G Turpie; T J Thomson
Journal:  Gut       Date:  1965-12       Impact factor: 23.059

5.  Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation.

Authors:  L Horwich; R Galloway
Journal:  Br Med J       Date:  1965-11-27

6.  Morphological observations on gastric ulcers treated with carbenoxolone sodium.

Authors:  T E Goodier; L Horwich; R W Galloway
Journal:  Gut       Date:  1967-12       Impact factor: 23.059

  6 in total
  14 in total

Review 1.  Some aspects of medical management of gastrointestinal disease. I.

Authors:  B W Badley
Journal:  Can Med Assoc J       Date:  1975-01-25       Impact factor: 8.262

2.  Carbenoxolone sodium: its role in ulcer healing.

Authors:  M J Langman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 3.  Medical management of peptic ulcer with reference to anti-ulcer agents in other gastro-intestinal diseases.

Authors:  D W Piper; T R Heap
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  Muscle paresis and hypokalemia after treatment with duogastrone.

Authors:  J Forshaw
Journal:  Br Med J       Date:  1969-06-14

5.  Peptic ulcer: surgical treatment.

Authors:  J L Dawson
Journal:  Br Med J       Date:  1969-10-11

6.  Carbenoxolone sodium capsules in the treatment of duodenal ulcer. An endoscopic controlled trial.

Authors: 
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

Review 7.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  The absorption of carbenoxolone administered orally as a positioned-release capsule.

Authors:  W E Lindup; D V Parke; D Colin-Jones
Journal:  Gut       Date:  1970-07       Impact factor: 23.059

9.  Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid.

Authors:  F D Henman
Journal:  Gut       Date:  1970-04       Impact factor: 23.059

10.  Evaluation of Duogastrome (carbenoxolone sodium) for the treatment of duodenal ulcer: a multicentre study.

Authors:  A Archambault; A Farley; D Gosselin; F Martin; J P Birkett
Journal:  Can Med Assoc J       Date:  1977-11-19       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.